You are here Home Vaccines Vaccines Varilrix Details for Varilrix (varicella) vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor GlaxoSmithKline Australia Administration route Subcutaneous injection Vaccine group Monovalent vaccines Description: Registered for use in people aged ≥9 months. Monovalent varicella vaccine Lyophilised powder in a monodose vial with separate diluent. Each 0.5 mL reconstituted dose contains: ≥103.3 plaque-forming units of live attenuated varicella-zoster virus (Oka strain) lactose mannitol sorbitol neomycin For Product Information and Consumer Medicine Information about Varilrix visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Varicella (chickenpox) Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
